NASDAQ$RNAC

Selecta Biosciences Inc · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Headline financials

Total Revenue

$24.4M

Previous: $4.65M+425.8%
EPS (adj)

-$0.16

Previous: -$0.09-77.8%
Capital Expenditures

-$807K

Previous: -$625K-29.1%
Free Cash Flow

-$18.7M

Previous: -$10.4M-80.6%
Net Income

-$17.9M

Previous: -$9.73M-83.9%
Operating Income

-$1.97M

Previous: -$13.7M+85.7%
Gross Profit

$24.4M

Previous: $0.00
Cash & Equivalents

$115M

Previous: $146M-21.6%
Total Assets

$167M

Previous: $181M-7.6%
Stock-Based Comp

$1.9M

Previous: $1.3M+46.9%

Revenue & EPS history

Selecta Biosciences · Revenue · Quarterly

$24.4M

Q3 2021+425.8%vs Q3 2020
Beat estimate in 6 of 7 quarters(86%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

+0.3%

Avg return

Earnings day

-1.5%

Avg return

5 days after

+0.8%

Avg return

30 days after

36%

14 / 39 earnings

Positive

+43.0%

Q2 2022

Best reaction

-58.1%

Q3 2017

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.9%+14.2%
Q4 2025+31.7%+7.9%-10.2%
Q3 2025-1.6%-4.8%-10.3%
Q2 2025-6.6%+0.4%-5.7%
Q1 2025-5.0%-4.2%+5.9%
Q3 2024-0.5%-18.8%+20.5%
Q2 2024-5.9%-3.8%-8.7%
Q1 2024-5.8%-7.6%+57.6%
Q4 2023-8.6%-16.0%-36.6%
Q3 2023+11.7%+11.7%-26.6%
Q2 2023+3.7%+7.3%+4.6%
Q1 2023-6.1%+2.6%+11.3%
Q4 2022-3.1%-5.0%-13.1%
Q3 2022+0.6%-4.9%-18.4%
Q2 2022+43.0%+55.2%+10.9%
Q1 2022+7.4%-0.6%+10.2%
Q4 2021-5.7%-16.6%-32.0%
Q3 2021-6.1%-8.1%-23.5%
Q2 2021+13.1%+8.9%+15.4%
Q1 2021-0.7%+3.7%+65.4%
Q4 2020+9.5%+16.7%+7.2%
Q3 2020-8.2%-8.2%-2.7%
Q2 2020-4.7%-3.6%-21.6%
Q1 2020+1.3%+4.2%+17.5%
Q4 2019-12.3%-35.6%-28.5%
Q3 2019-8.4%-9.7%-1.3%
Q2 2019-6.3%-11.5%+3.1%
Q1 2019-4.8%-8.4%-9.6%
Q4 2018+37.8%+21.6%+22.1%
Q3 2018-5.0%-2.8%-7.4%
Q2 2018+0.9%-1.5%+3.8%
Q1 2018+1.3%+10.4%+16.1%
Q4 2017-16.6%-22.8%+7.4%
Q3 2017-58.1%-59.9%-56.0%
Q2 2017-1.4%-7.1%+3.8%
Q1 2017-2.1%+3.2%+9.3%
Q4 2016+16.1%+18.9%+5.7%
Q3 2016+27.2%+17.9%+20.3%
Q2 2016-4.6%-1.7%+25.4%
Q3 2015
Q2 2015
Q1 2015

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro